- Home
- SMHI vs OBIO Comparison
SMHI vs OBIO Comparison
Compare SMHI & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMHI
- OBIO
- Stock Information
- Founded
- SMHI 1989
- OBIO 2017
- Country
- SMHI United States
- OBIO United States
- Employees
- SMHI N/A
- OBIO N/A
- Industry
- SMHI Marine Transportation
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- SMHI Consumer Discretionary
- OBIO Health Care
- Exchange
- SMHI Nasdaq
- OBIO Nasdaq
- Market Cap
- SMHI 139.9M
- OBIO 118.8M
- IPO Year
- SMHI N/A
- OBIO N/A
- Fundamental
- Price
- SMHI $5.47
- OBIO $2.92
- Analyst Decision
- SMHI
- OBIO Strong Buy
- Analyst Count
- SMHI 0
- OBIO 5
- Target Price
- SMHI N/A
- OBIO $14.20
- AVG Volume (30 Days)
- SMHI 126.9K
- OBIO 365.7K
- Earning Date
- SMHI 07-30-2025
- OBIO 08-11-2025
- Dividend Yield
- SMHI N/A
- OBIO N/A
- EPS Growth
- SMHI N/A
- OBIO N/A
- EPS
- SMHI N/A
- OBIO N/A
- Revenue
- SMHI $264,089,999.00
- OBIO $2,886,000.00
- Revenue This Year
- SMHI N/A
- OBIO $20.47
- Revenue Next Year
- SMHI $11.59
- OBIO $11.45
- P/E Ratio
- SMHI N/A
- OBIO N/A
- Revenue Growth
- SMHI N/A
- OBIO 30.23
- 52 Week Low
- SMHI $3.63
- OBIO $2.37
- 52 Week High
- SMHI $15.36
- OBIO $8.87
- Technical
- Relative Strength Index (RSI)
- SMHI 48.57
- OBIO 51.99
- Support Level
- SMHI $5.39
- OBIO $2.89
- Resistance Level
- SMHI $5.90
- OBIO $3.08
- Average True Range (ATR)
- SMHI 0.27
- OBIO 0.20
- MACD
- SMHI -0.00
- OBIO 0.01
- Stochastic Oscillator
- SMHI 51.04
- OBIO 62.86
About SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.